Prevalence of Life Style Drugs Usage and Perceived Effects among University Students in Dar es Salaam

Kennedy D. Mwambete^1, and Theresia Shemsika¹

¹Department of Pharmaceutical Microbiology, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania

Cite this paper:
Kennedy D. Mwambete and Theresia Shemsika. Prevalence of Life Style Drugs Usage and Perceived Effects among University Students in Dar es Salaam. American Journal of Biomedical Research. 2014; 2(2):29-35. doi: 10.12691/ajbr-2-2-3

Abstract

This was a cross-sectional study involving randomly selected university students from University of Dar es Salaam (UDSM) and Muhimbili University of Health and Allied Sciences (MUHAS). Each respondent filled in a consent form prior to an interview. Awareness and prevalence of LSD usage, perceived effects and personal opinions on LSD usefulness were investigated. A total of 310 students (222 males and 88 females) aged between 21 and 35 years were interviewed. About 56.5% (n=175) were non-medical students from UDSM while 135 (43.5%) were medical students from MUHAS. Majority (92%) of the students was aware of LSDs, though only 29.3% of them had used one of 10 tracer LSDs, while 18 (5.8 %) students were uncertain whether they had ever used LSDs or not. Over 81% of LSD users had used alcohols and 43% of those admitted to have been propelled by peer pressure. Euphoria and “good sleep” were the mentioned by 27% of LSDs users as motive for consuming them, while 32.5% said LSDs usage added an extra-financial burden. This is the first study on the prevalence of LDS usage in universities.

Keywords:
life style drugs adverse effects easy availability of drugs

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Rahman, S., Gupta, V., Sukhlecha, A., & Khunte, Y. Lifestyle drugs: Concept and impact on society. Indian journal of pharmaceutical sciences, 72 (4), 409. 2010.
[2]	Everitt, D.E., Avorn, J., Baker, M.W. Clinical decision-making in the evaluation and treatment of insomnia. American Journal of Medicine, 89:357-62. 1990.
[3]	Gilbert, D., Walley, T., and New, B. Lifestyle medicines. British Medical Journal, 321 (7272), 1341, 2000.
[4]	Flower, R.J. Lifestyle and non-medical use of drugs. In: Rang HP. Dale MM, Ritter JM. editors. Rang and Dale’s pharmacology. 6th ed. London: Churchill living stone; 2007, 765-9.
[5]	Ashworth, M., Clement, S., & Wright, M. Demand, appropriateness and prescribing of ‘lifestyle drugs’: a consultation survey in general practice. Family Practice, 19 (3), 236-241, 2002.
[6]	Young, S.N. Lifestyle drugs, mood, behavior and cognition. Journal of Psychiatry Neuroscience, 28 (2): 87-9, 2003.
[7]	Moynihan, R., Heath, I., Henry, D. selling sickness-The pharmaceutical industry and disease mongering. British Medical Journal, 324: 886-91, 2002.
[8]	Outram, S.M. The use of methylphenidate among students: the future of enhancement? Journal of Medical Ethics 36: 198-202, 2010.
[9]	Powell, R., Kahane, G., & Savulescu, J. Evolution, Genetic Engineering, and Human Enhancement. Philosophy & Technology, 25 (4), 439-458, 2012.
[10]	Fox, N. J., & Ward, K. J. Pharma in the bedroom... and the kitchen.... The pharmaceuticalisation of daily life. Sociology of health & illness, 30 (6), 856-868, 2008.
[11]	Shakespeare, J., Neve, E. and Hodder, K. Is norethisterone a lifestyle drug? Results of database analysis, British Medical Journal, 320, 291, 2000.
[12]	Aronson, J.K. From prescription-only to over-the-counter medicines (‘PoM to P'): time for an intermediate category. Br Med Bull 90: 63-69, 2009.
[13]	Coveney, C.M. Awakening expectations: Exploring social and ethical issues surrounding the medical and non-medical uses of cognition enhancing drugs in the UK (Doctoral dissertation, University of Nottingham), 2010.
[14]	Sapolsky, R.M. Why stress is bad for your brain. Science, 273: 749-750, 1996.
[15]	Lucke, J.C., Bell, S.K., Oatridge, B.J., and Hall, W.D. Academic doping or Viagra for the brain? The history of recreational drug use and pharmacological enhancement can provide insight into these uses of neuropharmaceuticals. EMBO Report, 12 (3): 197-201, March 3, 2011.
[16]	Fox, N. J., Ward, K. J., & O’Rourke, A. J. The ‘expert patient’: empowerment or medical dominance? The case of weight loss, pharmaceutical drugs and the Internet. Social Science & Medicine, 60 (6), 1299-1309, 2005.
[17]	Flower, R. Lifestyle drugs: pharmacology and the social agenda. Trends in Pharmacological Sciences, 25 (4), 182-185, 2004.
[18]	Edwards, I. R., & Aronson, J. K. Adverse drug reactions: definitions, diagnosis, and management. The Lancet, 356 (9237), 1255-1259, 2000.
[19]	Use, Food, Herbal Use, Toxicity Side-effects, and Warnings Contra-indications. “Martindale: the complete drug reference.” 2007.
[20]	Rose SPR. ‘Smart Drugs’: Do they work? Are they ethical? Will they be legal? Nature Reviews Neuroscience, 3: 975-9, 2002.
[21]	Fox, N.J. and Ward, K.J. Health identities: from expert patient to resisting consumer, Health, 10, 4, 461-79, 2006.
[22]	Shrier, L. A., Emans, S. J., Woods, E. R., & DuRant, R. H. The association of sexual risk behaviors and problem drug behaviors in high school students. Journal of Adolescent Health, 20 (5), 377-383, 1997
[23]	Little, A., & Roberts, S.C. Evolution, appearance, and occupational success. Evolutionary psychology: an international journal of evolutionary approaches to psychology and behavior, 10 (5), 782-801, 2012.
[24]	Ross, R., Freeman, J. A., & Janssen, I. Exercise alone is an effective strategy for reducing obesity and related comorbidities. Exercise and sport sciences reviews, 28 (4), 165-170, 2000.
[25]	Lexchin, J. Lifestyle drugs: issues for debate, Canadian Medical Association Journal, 164, 10, 1449-51, 2001.
[26]	Coveney, C. M., Nerlich, B., & Martin, P. Modafinil in the media: Metaphors, medicalisation and the body. Social Science & Medicine, 68 (3), 487-495, 2009.
[27]	Himle, J. A., Abelson, J. L., Haghightgou, H., Hill, E. M., Nesse, R. M., & Curtis, G. C. Effect of alcohol on social phobic anxiety. American Journal of Psychiatry, 156 (8), 1237-1243, 1999.
[28]	Burke, R.S., and Stephens, R.S. Social anxiety and drinking in college students: A social cognitive theory analysis. Clinical Psychology Reviews, 19 (5): 513-530, 1999.
[29]	Hallfors, D. D., Waller, M. W., Bauer, D., Ford, C. A., & Halpern, C. T. Which comes first in adolescence—sex and drugs or depression? American Journal of Preventive Medicine, 29 (3), 163-170, 2005.
[30]	Rehm, J., Sulkowska, U., Mańczuk, M., Boffetta, P., Powles, J., Popova, S., & Zatoński, W. Alcohol accounts for a high proportion of premature mortality in central and eastern Europe. International journal of epidemiology, 36 (2), 458-467, 2007.
[31]	Harrison, L., & Gardiner, E. Do the rich really die young? Alcohol‐related mortality and social class in Great Britain, 1988‐94. Addiction, 94 (12), 1871-1880, 1999.
[32]	Spencer, R.L., and Hutchison, K.E. Alcohol, aging, and the stress response. Alcohol Research & Health 23 (4): 272-283, 1999.
[33]	Webb, E., Ashton, C. H., Kelly, P., & Kamali, F. (1996). Alcohol and drug use in UK university students. The lancet, 348 (9032), 922-925.
[34]	Blay, Y.A. Skin bleaching and global white supremacy: By way of introduction. Journal of Pan African Studies, 4 (4), 2011.
[35]	Lewis, K. M., Harris, S., Camp, C., Kalala, W., Jones, W., Ellick, K. L. & Younge, S. The Historical and Cultural Influences of Skin Bleaching in Tanzania. In The Melanin Millennium Springer Netherlands, 2013, 19-38.
[36]	Archer, J., Archer, D. “Oral contraceptive efficacy and antibiotic interaction: a myth debunked.” Journal of American Academy of Dermatology, 46 (6): 917-23, 2002.
[37]	Brito, M.B., Nobre, F., Vieira, C.S. “Hormonal contraception and cardiovascular system.” Arquivos brasileiros de cardiologia 96 (4): e81-9, Apr 2011.